| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Research and development | $26.6M-61.8% | $69.6M-22.1% | $89.4M+31.4% | $68.0M+174.2% | $24.8M | — |
| General and administrative | $68.8M-4.2% | $71.8M+334.3% | $16.5M+37.9% | $12.0M+48.8% | $8.1M+115.4% | $3.7M |
| Total operating expenses | $95.4M-32.6% | $141.4M+33.5% | $106.0M+32.4% | $80.0M+143.5% | $32.9M+409.9% | $6.4M |
| Operating loss | -$95.4M+32.6% | -$141.4M-33.5% | -$106.0M-32.4% | -$80.0M-143.5% | -$32.9M-409.9% | -$6.4M |
| Interest income | $4.6M-45.7% | $8.5M+8.6% | $7.8M+182.1% | $2.8M+5567.3% | $49K-56.3% | $112K |
| Other income (loss), net | -$203K-149.4% | $411K-54.7% | $907K-9.0% | $997K+129.7% | $434K | — |
| Gain from change in fair value of warrant liabilities | $0-100.0% | $108.2M | $0 | $0 | — | — |
| Net loss | -$91.0M-273.7% | -$24.3M+75.0% | -$97.2M-27.5% | -$76.2M-135.4% | -$32.4M-411.3% | -$6.3M |
| Shares used in computing net loss per share, basic (in shares) | $48297.00+4.2% | $46329.00+10.5% | $41932.00+4.3% | $40202.00+2.0% | $39405.00 | — |
| Net loss per share, basic (in dollars per share) | -$1.88-254.7% | -$0.53+77.2% | -$2.32-22.1% | -$1.90-131.7% | -$0.82 | — |
| Adjustment for change in fair value of warrant liabilities | $0+100.0% | -$43.8M | $0 | $0 | — | — |
| Adjusted numerator, diluted | -$91.0M-33.5% | -$68.1M+29.9% | -$97.2M-27.5% | -$76.2M | — | — |
| Shares used in computing net loss per share, diluted (in shares) | $48297.00+3.6% | $46604.00+11.1% | $41932.00+4.3% | $40202.00 | — | — |
| Net loss per share, diluted (in dollars per share) | -$1.88-28.8% | -$1.46+37.1% | -$2.32-22.1% | -$1.90 | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.